Nan Fung Group Holdings’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Hold |
30,875
| – | – | 2.12% | 13 |
|
|
2025
Q1 | $845K | Hold |
30,875
| – | – | 0.69% | 25 |
|
|
2024
Q4 | $1.24M | Buy |
30,875
+20,000
| +184% | +$805K | 1.06% | 24 |
|
|
2024
Q3 | $515K | Hold |
10,875
| – | – | 0.44% | 30 |
|
|
2024
Q2 | $325K | Hold |
10,875
| – | – | 0.35% | 31 |
|
|
2024
Q1 | $437K | Buy |
+10,875
| New | +$437K | 0.41% | 34 |
|
|
2022
Q1 | – | Sell |
-4,960
| Closed | -$315K | – | 51 |
|
|
2021
Q4 | $315K | Buy |
+4,960
| New | +$315K | 0.09% | 39 |
|